John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 100,000 shares at $29.14 ($2.8M) on 2022-12-05, disclosed to the SEC on 2022-12-06.
Open-market sale of $2.8M VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.16 | 46,706 | $1.3M | 46.6% |
| 2 | $28.16 | 46,706 | $1.3M | 46.6% |
| 3 | $29.14 | 3,294 | $96K | 3.4% |
| 4 | $29.14 | 3,294 | $96K | 3.4% |
| Total | $28.22 avg | 100,000 | $2.8M | 100% |
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |